Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should You Buy Ocugen Stock?

TheMotleyFool

0 0

Some stocks come seemingly out of nowhere but are huge winners. You can put Ocugen (NASDAQ: OCGN) in that category. As of Dec. 21, 2020, its shares were down 43% year to date. The next day, though, Ocugen announced that it was teaming up with Bharat Biotech to co-develop COVID-19 vaccine candidate Covaxin for the U.S. market.

Since then, the stock has skyrocketed more than 3,600% and even doubled just last week. Previously little-known Ocugen now ranks among the most popular stocks on Robinhood -- and it's caught the attention of many investors who don't trade on Robinhood, too.

Should you buy Ocugen stock now? Here are the arguments both for and against the high-flying biotech stock.

Source Fool.com

Like: 0

OCGN

Share